MycoWorks Launches World’s Largest Mycelium Material Facility In South Carolina
Biotech firm MycoWorks has initiated production at its state-of-the-art manufacturing plant in Union, South Carolina. This facility can scale up production to meet the luxury industry’s demand for its proprietary Fine Mycelium material. The patented technology produces Reishi, a biomaterial with hand-feel, strength and durability comparable to calfskin leather.
With partners like Hermès and General Motors, MycoWorks’ transition to large-scale manufacturing signifies the maturation of the biomaterials industry. MycoWorks aims to address challenges in the $164 billion leather and $28 billion luxury leather markets, including supply chain constraints and inferior alternatives.
The 136,000 sq. ft. factory is also the world’s largest mycelium material operation, marking a significant step for mycelium use. The project was funded through a $125 million Series C round in 2021. The facility employs advanced robotics, AI and digital analytics to ensure high-quality, low-cost production with full predictability and transparency, reshoring production from Europe to South Carolina.
MycoWorks’ Fine Mycelium has found applications in luxury fashion, automotive and home furnishings. Governor Henry McMaster welcomed the company’s investment as it brings growth and innovation to the region.